SGLT2 Inhibitors in Diabetic Kidney Disease | 合法藥品大搜索

由SZoungas著作·2020·被引用1次—Type2diabetes,increasinginprevalenceglobally,isamajorcauseofCKDandkidneyfailure.Sodium-glucosetransportprotein2inhibitors( ...

%PDF-1.4 % 1 0 obj > endobj 4 0 obj >stream Acrobat Distiller 10.0.0 (Windows)doi:10.2215/CJN.18881220application/pdfSGLT2 Inhibitors in Diabetic Kidney Disease http://cjasn.asnjournals.org/ 10.2215/CJN.18881220http://dx.doi.org/10.2215/CJN.188812202021-02-03false10.2215/CJN.18881220http://cjasn.asnjournals.org/ http://cjasn.asnjournals.org/ 10.2215/CJN.188812202021-02-03falsehttp://cjasn.asnjournals.org/ 2021-02-03T03:09:43+05:30Arbortext Advanced Print Publisher 9.1.510/W Unicode2021-02-04T08:53:45-08:002021-02-04T08:53:45-08:00uuid:3cc97c9b-1dd2-11b2-0a00-5d09275d6100uuid:07e6f18b-1dd2-11b2-0a00-9000c8c2e6ff endstream endobj 3 0 obj > endobj 2 0 obj > endobj 5 0 obj >/ExtGState>/Font>/ProcSet[/PDF/Text/ImageC/ImageI]/Properties>/Shading>/XObject>>>/Rotate 0/Thumb 9 0 R/Type/Page>> endobj 6 0 obj >/ExtGState&g...

探討SGLT2 抑制劑對於第2 型糖尿病合併慢性腎疾病的影響與 ... | 合法藥品大搜索

由吳芳仁著作 — 糖尿病是慢性腎臟疾病的主要原因之一，SGLT2 抑制劑為治療第2 型糖尿病的新型口服. 降血糖藥物，臨床 ... 關鍵詞：慢性腎臟病(Chronic kidney disease, CKD). Read More

新世代護腎藥出現：Dapagliflozin可改善腎病變患者的預後 ... | 合法藥品大搜索

2020年9月4日 — 值得一提的是，DAPA-CKD研究在今年三月因為發現它的藥物介入有明顯勝過安慰劑的好處而提早終止研究。 SGLT2抑制劑在心血管安全報告中 ... Read More

SGLT2抑制劑Dapagliflozin可用在腎功能不佳患者– 糖尿病筆記 | 合法藥品大搜索

2019年3月3日 — SGLT2抑制劑是新類別的血糖藥，透過尿液排糖效果，來達到控糖的目的。目前台灣有三種SGLT2抑制劑，Empagliflozin，Dapagliflozin， ... Read More

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type ... | 合法藥品大搜索

由 KR Tuttle 著作 · 被引用 8 次 — SGLT2 inhibitors improve glomerular hemodynamic function and are thought to ameliorate other local and systemic mechanisms involved in the ... Read More

SGLT2 Inhibition for CKD and Cardiovascular ... | 合法藥品大搜索

由 KR Tuttle 著作 · 2021 · 被引用 8 次 — SGLT2 inhibitors improve glomerular hemodynamic function and are thought to ameliorate other local and systemic mechanisms involved in the ... Read More

Efficacy and renal outcomes of SGLT2 inhibitors in patients ... | 合法藥品大搜索

由 MS Kelly 著作 · 2019 · 被引用 37 次 — Conclusions: In patients with T2DM and CKD, SGLT2 inhibitors have a decreased glucose-lowering effect compared to patients without CKD. Renal benefits ... Read More

SGLT2 Inhibitors in Diabetic Kidney Disease | 合法藥品大搜索

由 S Zoungas 著作 · 2020 · 被引用 1 次 — Type 2 diabetes, increasing in prevalence globally, is a major cause of CKD and kidney failure. Sodium- glucose transport protein 2 inhibitors ( ... Read More

SGLT2 Inhibitors | 合法藥品大搜索

由 DC Wheeler 著作 · 2020 · 被引用 4 次 — SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in ... Oral glucose-lowering medicines, SGLT2 inhibitors, Type 2 diabetes. Read More

SGLT2 inhibition and chronic kidney disease outcomes | 合法藥品大搜索

由 KR Tuttle 著作 — Over the past 5 years, SGLT2 inhibitors have been shown to deliver remarkable benefits with respect to reduced risks of cardiovascular events ... Read More

相關資訊整理